Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

Kenneth L. Rock, Colette F. Gramm, Lisa Rothstein et al. · Cell · 1994 · 2.5K citations

Proteasome Block, Biochemistry, Mhc Class +13

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Pierre G. Coulie, Vincent Brichard, Aline Van Pel et al. · The Journal of Experimental Medicine · 1994 · 914 citations · Full text

Histocompatibility, Lymphocyte Development, Hla Immunogenetics +21

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.

J O’Connell, Gerald C. O’Sullivan, John Collins et al. · The Journal of Experimental Medicine · 1996 · 888 citations · Full text

Apoptosis, Immunology, Immune Regulation +19

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.

Bryan Fisk, Tana Blevins, J. Taylor Wharton et al. · The Journal of Experimental Medicine · 1995 · 542 citations · Full text

Cancer Immunosurveillance, Synthetic Peptide Analogues, Immunology +15

Polyubiquitination and Proteasomal Degradation of the p185c-B-2 Receptor Protein-tyrosine Kinase Induced by Geldanamycin

Edward G. Mimnaugh, Christine Chavany, Len Neckers · Journal of Biological Chemistry · 1996 · 464 citations · Full text